Get 40% Off
👀 👁 🧿 All eyes on Biogen, up +4,56% after posting earnings. Our AI picked it in March 2024.
Which stocks will surge next?
Unlock AI-picked Stocks

After-Hours Movers: Cassava Sciences Surges on Insider Buy, Agilent Gains Post EPS

Published 17/08/2022, 07:44 am
Updated 17/08/2022, 07:44 am
© Reuters.

After-Hours Stock Movers:

Cassava Sciences (NASDAQ:SAVA) 20% HIGHER; Director Stanford Robertson bought $2 million in stock.

Blue Apron Holdings Inc (NYSE:APRN)18% HIGHER; adds to intra-day gains.

AerSale Corp (NASDAQ:ASLE7% LOWER; announced that certain of its stockholders, including affiliates of Leonard Green & Partners, L.P. (the Selling Stockholders) intend to offer for sale in an underwritten secondary offering 4,250,000 shares of common stock of AerSale pursuant to a shelf registration statement

Canoo Inc. (GOEV) 6% HIGHER; CEO Tony Aquila bought 200K shares.

Agilent Technologies (NYSE:A) 6% HIGHER; reported Q3 EPS of $1.34, $0.14 better than the analyst estimate of $1.20. Revenue for the quarter came in at $1.72 billion versus the consensus estimate of $1.64 billion. Agilent Technologies sees Q4 2022 EPS of $1.38-$1.40, versus the consensus of $129.00. Agilent Technologies sees Q4 2022 revenue of $1.75-1.775 billion, versus the consensus of $1.71 billion.

Option Care Health, Inc. (NASDAQ:OPCH) 5% LOWER; announced today that an affiliate of Walgreens Boots Alliance (NASDAQ:WBA), Inc. has agreed to sell 11,000,000 shares of the Company's common stock in an underwritten secondary offering.

Bed Bath & Beyond Inc . (NASDAQ:BBBY) 5% HIGHER; adds to recent gains, including 29% intra-day gain.

Quanterix (NASDAQ:QTRX) 4% HIGHER; The CEO and CFO both bought stock.

Jack Henry (JKHY) 4% LOWER; reported Q4 EPS of $1.10, $0.10 better than the analyst estimate of $1.00. Revenue for the quarter came in at $482.7 million versus the consensus estimate of $480.3 million. Jack Henry sees FY2023 EPS of $5.05-$5.09, versus the consensus of $5.23. Jack Henry sees FY2023 revenue of $2.08-2.09 billion, versus the consensus of $2.08 billion.

3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

Oak Street Health, Inc. (OSH) 4% LOWER; announced the commencement of an underwritten public offering of 7,000,000 shares of its common stock by a selling stockholder.

Lulu's Fashion Lounge Holdings, Inc. (LVLU) 4% HIGHER; reported Q2 EPS of $0.15, $0.07 worse than the analyst estimate of $0.22. Revenue for the quarter came in at $131.5 million versus the consensus estimate of $133.18 million. Lulu's Fashion Lounge Holdings, Inc. reaffirms Q3 2022 revenue of $440-480 million.

UNITY Biotechnology, Inc. (Nasdaq: UBX) 4% LOWER; announced that it has commenced a proposed underwritten public offering of $25.0 million of shares of its common stock

Quicklogic Corp (QUIK) 2% HIGHER; reported Q2 EPS of $0.00, $0.03 better than the analyst estimate of ($0.03). Revenue for the quarter came in at $4.5 million versus the consensus estimate of $4.47 million.

 

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.